-
Multicenter Study Comparative Study Clinical Trial
The restore rechargeable, implantable neurostimulator: handling and clinical results of a multicenter study.
- Jean-Pierre Van Buyten, Sylvain Fowo, Geert H Spincemaille, Volker Tronnier, Guus Beute, Jorge J Pallarés, Hussein Naous, Furio Zucco, Joachim K Krauss, José De Andrés, Eric Buchser, Amedeo Costantini, and Yves Lazorthes.
- AZ Nikolaas-Campus SM, Sint-Niklaas, Belgium. jeanpierre.vanbuyten@mariamiddelares.be
- Clin J Pain. 2008 May 1;24(4):325-34.
BackgroundSpinal cord stimulation is an effective therapy for chronic, neuropathic pain refractory to medication. Use of a rechargeable neurostimulation system (Restore, Medtronic Inc) could provide greater longevity in the treatment of complex pain. However, patients' ability to successfully recharge a neurostimulation system has not yet been demonstrated.Primary ObjectiveAbility of patients to recharge the neurostimulator.Secondary ObjectivesPatient and physician satisfaction with the system, pain relief, quality of life, functional status, adverse events.MethodsProspective, open-label, multicenter, European study in patients with long-term refractory neuropathic pain. Recharging ability was assessed 1-month postimplant. Patient and physician satisfaction, pain relief, quality of life, and functional status were assessed at scheduled follow-up visits through 12 months. Adverse events were monitored throughout.ResultsPrimary end point: 100% of patients (n=41) successfully recharged the neurostimulator. Secondary end points at 1 month: 78.6% of patients found recharging easy. At 12 months: physicians were satisfied with the system for 92.7% of patients; pain intensity decreased significantly (P<0.001); mean self-reported pain relief was 62%; 80.5% of patients had more than 50% pain relief; quality of life and functional status improved significantly (P<0.001); 98% of patients would recommend spinal cord stimulation to others. Overall, 41 device-related complications (23 patients) were observed.ConclusionsTwelve-month experience indicates that the rechargeable neurostimulation system (Restore) was easy to use, with 100% of patients able to recharge successfully. Patient and physician satisfaction was high, with significant improvements in pain, quality of life, and functional status. Complications were comparable to prior experience with this therapy.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.